Data from the EHA 2026 conference shows blinatumomab significantly outperformed standard chemotherapy in treating high-risk B-cell acute lymphoblastic leukaemia.
Tag: chemotherapy
Pembrolizumab Favoured Over Chemotherapy for Patients With Pulmonary Side Effects
New data at a 2026 conference showed pembrolizumab was associated with fewer pulmonary adverse events than chemotherapy for certain cancer patients.